Editorial: mesalazine and mucosal microbiome in quiescent ulcerative colitis—what can we learn?

Abstract

Linked ContentThis article is linked to Olaisen et al and Olaisen and Fossmark papers. To view these articles, visit https://doi.org/10.1111/apt.15227 and https://doi.org/10.1111/apt.15285.

Editorial: mesalamine and mucosal microbiome in quiescent ulcerative colitis—what can we learn? Authors' reply

“…We welcome the interest expressed by Buchner and Lichtenstein in our work examining mucosal mesalazine concentration in relation to various factors, including the microbiome composition in mucosal biopsies and faecal samples from patients with ulcerative colitis (UC) …”